Form 4: SOPHiA GENETICS CSO Sells Shares for Tax Obligations

SOPHiA GENETICS Chief Sales Officer Kevin Puylaert sold 3 ordinary shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Kevin Puylaert, Chief Sales Officer of SOPHiA GENETICS SA, reported a transaction involving the company's ordinary shares.
• The transaction occurred on March 31, 2026, and involved the sale of 3 ordinary shares at a price of $4.71 per share.
• The sale was a 'sell to cover' transaction, executed to satisfy tax obligations in connection with the vesting of restricted stock units (RSUs) on March 30, 2026.
• This was not a discretionary trade but rather a pre-arranged transaction under a Rule 10b5-1(c) plan.
• Following this transaction, Kevin Puylaert beneficially owns 92,383 ordinary shares directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive or neutral event. While it's a sale, it's a routine, non-discretionary 'sell to cover' transaction for tax purposes, which is a common practice and does not signal a lack of confidence from management.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The shares were sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units.
• The sales were effected as a 'sell to cover' transaction and do not represent discretionary trades.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine practice for executives and employees when restricted stock units or options vest. These sales are typically pre-arranged under Rule 10b5-1 plans and are not indicative of management's discretionary view on the company's stock performance, distinguishing them from open market sales driven by investment decisions.

Key Dates

Recommendation

This transaction is a routine, non-discretionary 'sell to cover' for tax obligations, involving a very small number of shares (3). It does not reflect a change in the insider's investment sentiment or the company's fundamentals, and therefore, has no material impact on the stock's investment thesis. A seasoned investor would likely maintain their current position based solely on this filing.

Keywords

SOPHiA GENETICS, SOPH, Insider Transaction, Form 4, Kevin Puylaert, Share Sale, Tax Obligations, RSU Vesting, Sell to Cover